These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35864499)

  • 1. Circulating amino acids and acylcarnitines correlated with different CAC score ranges in diabetic postmenopausal women using LC-MS/MS based metabolomics approach.
    Hosseinkhani S; Salari P; Bandarian F; Asadi M; Shirani S; Najjar N; Dehghanbanadaki H; Pasalar P; Razi F
    BMC Endocr Disord; 2022 Jul; 22(1):186. PubMed ID: 35864499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between acylcarnitine and amino acids profile and metabolic syndrome and its components in Iranian adults: Data from STEPs 2016.
    Taghizadeh H; Emamgholipour S; Hosseinkhani S; Arjmand B; Rezaei N; Dilmaghani-Marand A; Ghasemi E; Panahi N; Dehghanbanadaki H; Ghodssi-Ghassemabadi R; Najjar N; Asadi M; Khoshniat M; Larijani B; Razi F
    Front Endocrinol (Lausanne); 2023; 14():1058952. PubMed ID: 36923214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted metabolomics analysis of amino acids and acylcarnitines as risk markers for diabetes by LC-MS/MS technique.
    Hosseinkhani S; Arjmand B; Dilmaghani-Marand A; Mohammadi Fateh S; Dehghanbanadaki H; Najjar N; Alavi-Moghadam S; Ghodssi-Ghassemabadi R; Nasli-Esfahani E; Farzadfar F; Larijani B; Razi F
    Sci Rep; 2022 May; 12(1):8418. PubMed ID: 35589736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the association between amino acid and acylcarnitine profiles and different levels of coronary artery disease risk in postmenopausal women using targeted metabolomics technique.
    Hosseinkhani S; Emamgholipour S; Salari P; Khalagi K; Shirani S; Najjar N; Larijani B; Pasalar P; Razi F
    Menopause; 2022 Sep; 29(9):1062-1070. PubMed ID: 35969879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Serum Acylcarnitines with Clinical Presentation and Severity of Coronary Artery Disease.
    Deda O; Panteris E; Meikopoulos T; Begou O; Mouskeftara T; Karagiannidis E; Papazoglou AS; Sianos G; Theodoridis G; Gika H
    Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous quantification of cardiovascular disease related metabolic risk factors using liquid chromatography tandem mass spectrometry in human serum.
    Wang M; Yang R; Dong J; Zhang T; Wang S; Zhou W; Li H; Zhao H; Zhang L; Wang S; Zhang C; Chen W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1009-1010():144-51. PubMed ID: 26735710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An LC-MS/MS method to quantify acylcarnitine species including isomeric and odd-numbered forms in plasma and tissues.
    Giesbertz P; Ecker J; Haag A; Spanier B; Daniel H
    J Lipid Res; 2015 Oct; 56(10):2029-39. PubMed ID: 26239049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Targeted Metabolomics Analysis for Amino Acids and Acylcarnitines in Patients with Prediabetes, Type 2 Diabetes Mellitus, and Diabetic Vascular Complications.
    Li X; Li Y; Liang Y; Hu R; Xu W; Liu Y
    Diabetes Metab J; 2021 Mar; 45(2):195-208. PubMed ID: 33685035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventional Left Atrial Appendage Closure Affects the Metabolism of Acylcarnitines.
    Fastner C; Behnes M; Sartorius B; Wenke A; Lang S; Yücel G; Sattler K; Rusnak J; Saleh A; Barth C; Mashayekhi K; Hoffmann U; Borggrefe M; Akin I
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis.
    Jabbar Al-Rikabi SA; Etemadi A; Morad MM; Nowrouzi A; Panahi GS; Mondeali M; Toorani-Ghazvini M; Nasli-Esfahani E; Razi F; Bandarian F
    Endocrinol Diabetes Metab; 2024 May; 7(3):e00484. PubMed ID: 38739122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Walnut Consumption, Plasma Metabolomics, and Risk of Type 2 Diabetes and Cardiovascular Disease.
    Guasch-Ferré M; Hernández-Alonso P; Drouin-Chartier JP; Ruiz-Canela M; Razquin C; Toledo E; Li J; Dennis C; Wittenbecher C; Corella D; Estruch R; Fitó M; Ros E; Babio N; Bhupathiraju SN; Clish CB; Liang L; Martínez-González MA; Hu FB; Salas-Salvadó J
    J Nutr; 2021 Feb; 151(2):303-311. PubMed ID: 33382410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of thirteen kinds of amino acid and eight kinds of acylcarnitine in human serum by LC-MS/MS and its application to measure the serum concentration of lung cancer patients.
    Ni J; Xu L; Li W; Wu L
    Biomed Chromatogr; 2016 Nov; 30(11):1796-1806. PubMed ID: 27129889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of free carnitine and acylcarnitines in plasma by HILIC-ESI-MS/MS without derivatization.
    Peng M; Liu L; Jiang M; Liang C; Zhao X; Cai Y; Sheng H; Ou Z; Luo H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():12-8. PubMed ID: 23816563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes.
    Ha CY; Kim JY; Paik JK; Kim OY; Paik YH; Lee EJ; Lee JH
    Clin Endocrinol (Oxf); 2012 May; 76(5):674-82. PubMed ID: 21958081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association Between Acylcarnitine Metabolites and Cardiovascular Disease in Chinese Patients With Type 2 Diabetes Mellitus.
    Zhao S; Feng XF; Huang T; Luo HH; Chen JX; Zeng J; Gu M; Li J; Sun XY; Sun D; Yang X; Fang ZZ; Cao YF
    Front Endocrinol (Lausanne); 2020; 11():212. PubMed ID: 32431666
    [No Abstract]   [Full Text] [Related]  

  • 16. Lower Concentrations of Circulating Medium and Long-Chain Acylcarnitines Characterize Insulin Resistance in Persons with HIV.
    Bailin SS; Jenkins CA; Petucci C; Culver JA; Shepherd BE; Fessel JP; Hulgan T; Koethe JR
    AIDS Res Hum Retroviruses; 2018 Jun; 34(6):536-543. PubMed ID: 29607651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Acylcarnitines and Risk of Type 2 Diabetes in a Mediterranean Population at High Cardiovascular Risk.
    Guasch-Ferré M; Ruiz-Canela M; Li J; Zheng Y; Bulló M; Wang DD; Toledo E; Clish C; Corella D; Estruch R; Ros E; Fitó M; Arós F; Fiol M; Lapetra J; Serra-Majem L; Liang L; Papandreou C; Dennis C; Martínez-González MA; Hu FB; Salas-Salvadó J
    J Clin Endocrinol Metab; 2019 May; 104(5):1508-1519. PubMed ID: 30423132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterising the urinary acylcarnitine and amino acid profiles of HIV/TB co-infection, using LC-MS metabolomics.
    Pretorius C; Luies L
    Metabolomics; 2024 Aug; 20(5):92. PubMed ID: 39096437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of Acylcarnitine Species in db/db Mouse Using a Novel Method of High-Resolution Parallel Reaction Monitoring Reveals Widespread Metabolic Dysfunction Induced by Diabetes.
    Xiang L; Wei J; Tian XY; Wang B; Chan W; Li S; Tang Z; Zhang H; Cheang WS; Zhao Q; Zhao H; Yang Z; Hong Y; Huang Y; Cai Z
    Anal Chem; 2017 Oct; 89(19):10368-10375. PubMed ID: 28859482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS.
    Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H
    Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.